Skip to main content
SpringerLink
Log in

Marijuana and Bariatric Surgery

  • EATING DISORDERS (S WONDERLICH and S ENGEL, SECTION EDITORS)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Marijuana use presents a unique challenge to bariatric surgery programs. We review the recent evidence examining marijuana use on outcomes following bariatric surgery.

Recent Findings

Recent studies have not demonstrated an increased risk of short-term surgical complications or differences in up to 2-year weight loss following surgery among marijuana users. However, studies have demonstrated increased risks in two areas: pain management and problematic eating behaviors. Additionally, preoperative marijuana use has been linked to increased postoperative marijuana use which may undermine weight loss and increase risk for weight regain.

Summary

There are still many unanswered questions regarding marijuana use and bariatric surgery, and the limited literature base has produced mixed results when considering marijuana as a contraindication for bariatric surgery. Programs must take into consideration the laws of their state, individual patterns of use, and route of administration when considering whether marijuana is a contraindication for surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hales CM, Fryar CD, Carroll MD, Freedman DS, Aoki Y, Ogden CL. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA 2018: 319:2419–2429. https://doi.org/10.1001/jama.2018.7270

  2. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes. 2013;37:889–91.

    Article  CAS  Google Scholar 

  3. Nguyen NT. Blackstone RP. Ponce J, Rosenthal RJ. The ASMBS textbook of bariatric surgery. Springer: Morton JM; 2015.

    Google Scholar 

  4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  CAS  Google Scholar 

  5. ASMBS. New procedure estimates for bariatric surgery: what the numbers reveal. 2014; http://connect.asmbs.org/may-2014-bariatric-surgery-growth.html, 2016.

  6. Nguyen NT, Nguyen B, Smith B, Reavis KM, Elliott C, Hohmann S. Proposal for a bariatric mortality risk classification system for patients undergoing bariatric surgery. Surg Obes Relat Dis. 2013;2103(9):239–46.

    Article  Google Scholar 

  7. Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;2017(377):1143–55. https://doi.org/10.1056/NEJMoa1700459.

    Article  Google Scholar 

  8. Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA. 2018;153:427–34. https://doi.org/10.1001/jamasurg.2017.5025.

    Article  Google Scholar 

  9. Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310:2416–25. https://doi.org/10.1001/jama.2013.280928.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Puzziferri N, Roshek TB III, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery a systematic review. JAMA. 2014;312(9):934–42.

    Article  CAS  Google Scholar 

  11. Karmali S, Brar B, Shi X, Sharma AM, de Gara C, Birch DW. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–33.

    Article  Google Scholar 

  12. Sarwer DB, Heinberg LJ. A review of the psychosocial aspects of clinically severe obesity and bariatric surgery. Am Psychol. 2020;75(2):252–64.

    Article  Google Scholar 

  13. Mechanick JI, Youdim A, Jones DB, et al. Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity 2013:21(0 1):S1–27.

  14. Health NIo. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992:55(2 Suppl):615s–619s.

  15. Bauchowitz AU, Gonder-Frederick LA, Oblrisch M, et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med. 2005;67:825–32.

    Article  Google Scholar 

  16. Heinberg LJ, Pudalov L, Alameddin H, Steffen K. Opioids and bariatric surgery: a review and suggested recommendations for assessment and risk reduction. Surg Obes Relat Dis. 2019;15:314–21.

    Article  Google Scholar 

  17. Rummell C, Heinberg LJ. Assessing marijuana use in bariatric surgery candidates: Should it be a contraindication? Obes Surg 2014:24(10):1764–1770. There is no consensus on effects of cannabis use on bariatric surgery outcomes.

  18. King WC, Chen JY, Mitchell JE, Kalarchian MA, Steffen KJ, Engel SG, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307:2516–25.

    Article  CAS  Google Scholar 

  19. Mitchell JE, Selzer F, Kalarchian MA, Devlin MJ, Strain GW, Elder KA, et al. Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis. 2012;8:533–41.

    Article  Google Scholar 

  20. Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164:328–34.

    Article  Google Scholar 

  21. Clark MM, Balsiger BM, Sletten CD, Dahlman KL, Ames G, Williams DE, et al. Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes Surg. 2012;13:739–45. https://doi.org/10.1381/096089203322509318.

    Article  Google Scholar 

  22. Heinberg LJ, Ashton K. History of substance abuse relates to improved postbariatric body mass index outcomes. Surg Obes Relat Dis 2012:6:417–421. https://doi.org/10.1016/j.soard .2010.04.001.

  23. DrugFacts: marijuana [Internet]. Rockville (MD): National Institute on Drug Abuse (US), National Institutes of Health; 2019 [cited 2020 Aug 25]. Available from: http://www.drugabuse.gov/publications/ drugfacts/marijuana.

  24. Hudak J. 2014, a make or break year for legal pot [internet]. Washington DC: CNN Opinion; 2013. [cited 2020 Aug 25] Available from: http://www.cnn.com/2013/12/30/opinion/hudakmarijuana-2014/

    Google Scholar 

  25. Kumar N, Puljević C, Ferris J, Winstock A, Barratt MJ. Cannabis use patterns at the dawn of US cannabis reform. Journal of Cannabis Research. 2019 Dec;1(1):1–6.

    Article  Google Scholar 

  26. Goel A, McGuinness B, Jivraj NK, Wijeysundera DN, Mittleman MA, Bateman BT, et al. Cannabis use disorder and perioperative outcomes in major elective surgeries. A retrospective cohort analysis. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2020 Apr 1;132(4):625–35.

    Article  CAS  Google Scholar 

  27. Bauer FL, Donahoo WT, Hollis Jr HW, Tsai AG, Pottorf BJ, Johnson JM, Silveira LJ, Husain FA. Marijuana’s influence on pain scores, initial weight loss, and other bariatric surgical outcomes. The Permanente Journal. 2018; 22. The authors conclude that surgical outcomes at 30 days, improvement in medical conditions, and percentage of total body loss were not affected by marijuana use.

  28. Ambwani S, Boeka AG, Brown JD, Byrne TK, Budak AR, Sarwer DB, et al. Socially desirable responding by bariatric surgery candidates during psychological assessment. Surg Obes Relat Dis. 2013 Mar 1;9(2):300–5.

    Article  Google Scholar 

  29. Shockcor N, Adnan SM, Siegel A, Wise E, Zafar SN, Kligman M. Marijuana use does not affect the outcomes of bariatric surgery. Surgical endoscopy. 2020 Mar 12:1–5. No differences were found in the rate of 30-day postoperative complications or excess BMI lost from 3 weeks-2 years after surgery between marijuana users and non-users.

  30. Vidot DC, Prado G, De La Cruz-Munoz MD, Spadola C, Cuesta M, Messiah SE. Postoperative marijuana use and disordered eating among bariatric surgery patients. Surg Obes Relat Dis 2016:12:171–179. Results suggest that there is a subset of patients who engage in marijuana use after surgery despite recommendations against use. Increased or recent marijuana use was found to predict greater eating disordered behaviors.

  31. Huson HB, Granados TM, Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon. 2018 Sep 1;4(9):e00779.

    Article  Google Scholar 

  32. Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use–basic prevalence and related health outcomes: a scoping review and synthesis. Int J Drug Policy. 2018 Feb 1;52:87–96.

    Article  Google Scholar 

  33. Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL. Vaporization as a smokeless cannabis delivery system: a pilot study. Clinical Pharmacology & Therapeutics. 2007 Nov;82(5):572–8.

    Article  CAS  Google Scholar 

  34. Loflin M, Earleywine M. No smoke, no fire: what the initial literature suggests regarding vapourized cannabis and respiratory risk. Canadian Journal of Respiratory Therapy: CJRT= Revue Canadienne de la Thérapie Respiratoire: RCTR. 2015;51(1):7.

  35. Ghosh TS, Van Dyke M, Maffey A, Whitley E, Erpelding D, Wolk L. Medical marijuana’s public health lessons—implications for retail marijuana in Colorado. N Engl J Med. 2015 Mar 12;372(11):991–3.

    Article  CAS  Google Scholar 

  36. MacCoun RJ, Mello MM. Half-baked—the retail promotion of marijuana edibles. N Engl J Med. 2015 Mar 12;372(11):989–91.

    Article  CAS  Google Scholar 

  37. Geshtakovska G, Stefkov G. Routes of cannabis administration: a brief review. Your hosts Macedonian Pharmaceutical Association and Faculty of Pharmacy, Ss Cyril and Methodius University in Skopje. 2016;515.

  38. Grotenhermen F. Cannabinoids for therapeutic use. American Journal of Drug Delivery. 2004 Dec 1;2(4):229–40.

    Article  CAS  Google Scholar 

  39. Shiplo S, Asbridge M, Leatherdale ST, Hammond D. Medical cannabis use in Canada: vapourization and modes of delivery. Harm Reduct J. 2016 Dec 1;13(1):30.

    Article  Google Scholar 

  40. National Institute on Drug Abuse (US). Marijuana abuse [Internet]. Rockville (MD): National Institutes of Health (US); 2012 July. 12 p. Publication No.: 12–3859.

  41. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–9.

    Article  Google Scholar 

  42. Respiratory effects of marijuana [Internet]. Seattle (WA): University of Washington Alcohol and Drug Abuse Institute (US); 2013 Aug [cited 2020 Aug 25]. Available from: http://adai.washington.edu/ mariuana/factsheets/respiratoryeffects.pdf.

  43. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167:221–8.

    Article  Google Scholar 

  44. Aharonovich E, LiuX SS, et al. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry. 2005;162:1507–14.

    Article  Google Scholar 

  45. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;10:1811–20.

    Article  Google Scholar 

  46. Livingston EH. Obesity, psychological testing and substance abuse. Surg Obes Relat Dis. 2006;2:312.

    Article  Google Scholar 

  47. Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. J Addict Dis. 2005;24:95–100.

    Article  Google Scholar 

  48. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006 Feb;27(1):73–100.

    Article  CAS  Google Scholar 

  49. Meany G, Conceicao E, Mitchell JE. Binge eating, binge eating disorder and loss of control eating: effects on weight outcomes after bariatric surgery. Eur Eat Disord Rev. 2014;22(2):87–91. https://doi.org/10.1002/erv.2273.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sogg S. Alcohol misuse after bariatric surgery: epiphenomenon or “Oprah” phenomenon? Surg Obes Relat Dis. 2007;3:366–8.

    Article  Google Scholar 

  51. Sarwer DB, Allison KC, Wadden TA, Ashare R, Spitzer JC, McCuen-Wurst C. Psychopathology, disordered eating, and impulsivity as predictors of outcomes of bariatric surgery. Surg Obes Relat Dis. 2019;15:650–5.

    Article  Google Scholar 

  52. Ertelt TW, Mitchell JE, Lancaster K, Crosby RD, Steffen KJ, Marino JM. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis. 2008;4:647–50. https://doi.org/10.1016/j.soard.2008.01.004.

    Article  PubMed  Google Scholar 

  53. Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012;22:201–7.

    Article  Google Scholar 

  54. King WC, Chen JY, Courcoulas AP, et al. Alcohol and other substance use after bariatric surgery: Prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis 2017:13:1392–1402. Bariatric surgery increases risk of using illicit drugs and undergoing substance use treatment.

  55. King WC, Chen JY, Courcoulas AP, Dakin GF, Engel SG, Flum DR, et al. Alcohol and other substance use after bariatric surgery: prospective evidence from a US multicenter cohort study. Surg Obes Relat Dis. 2017 Aug 1;13(8):1392–402.

    Article  Google Scholar 

  56. Conason A, Teixeira J, Hsu CH, Puma L, Knafo D, Geliebter A. Substance use following bariatric weight loss surgery. JAMA 2013:148: 145–150. org/https://doi.org/10.1001/2013.jamasurg.265

  57. Ivezaj V, Saules KK, Schuh LM. New-onset substance use disorder after gastric bypass surgery: rates and associated characteristics. Obes Surg. 2014;24:1975–80.

    Article  Google Scholar 

  58. Lent MR, Hayes SM, Wood GC, Napolitano MA, Argyropoulos G, Gerhard GS, et al. Smoking and alcohol use in gastric bypass patients. Eat Beh. 2013;14:460–3.

    Article  Google Scholar 

  59. Reslan S, Saules KK, Greenwald MK, Schuh LM. Substance misuse following Roux-en-Y gastric bypass surgery. Subst Use Misuse. 2014;49:405–17.

    Article  Google Scholar 

  60. Raebel MA, Newcomer SR, Bayliss EA, Boudreau D, DeBar L, Elliott TE, et al. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014;23(12):1247–57.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Bariatric & Metabolic Institute, 9500 Euclid Ave, Cleveland, OH, 44195, USA

    Allyson Diggins

  2. Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Bariatric & Metabolic Institute, Cleveland, OH, USA

    Leslie Heinberg

Authors
  1. Allyson Diggins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie Heinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allyson Diggins.

Ethics declarations

Conflict of Interest

Allyson Diggins and Leslie Heinberg declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Eating Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diggins, A., Heinberg, L. Marijuana and Bariatric Surgery. Curr Psychiatry Rep 23, 10 (2021). https://doi.org/10.1007/s11920-020-01218-4

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11920-020-01218-4

Keywords

Search

Navigation